文献速递头颈部肿瘤放疗放疗物理与技术

离体与在体照射肿瘤样本的残余γH2AX反映相近的放射反应

Comparable radiation response of ex vivo and in vivo irradiated tumor samples determined by residual γH2AX.
PubMed 文献 · Radiother Oncol · 2019-08-21

研究用5种人头颈鳞癌(hHNSCC)异种移植模型,比较在体单次照射(0、2、4、8 Gy)与离体再氧合后等剂量照射的肿瘤活检组织残余γH2AX焦点剂量反应曲线。5种模型中4种的在体与离体曲线斜率相近,且离体活检与在体肿瘤的斜率均可按固有放射敏感性(TCD50)将模型分类为敏感或抗拒。

要点

  • 离体照射活检的残余γH2AX焦点剂量反应可反映在体肿瘤的放射反应。
  • 5种hHNSCC模型中4种在体与离体曲线斜率相近。
  • 离体与在体斜率均可按TCD50将肿瘤模型分类为敏感或抗拒。

核心结论

  • 离体照射的肿瘤活检能够反映并预测在体肿瘤的固有放射反应,提升离体γH2AX焦点检测作为临床诊断工具的转化潜力。

研究设计与样本

  • 采用5种人头颈鳞癌(hHNSCC)异种移植模型,在麻醉荷瘤NMRI裸鼠中于在体单次照射(0、2、4、8 Gy)前取细针活检,活检离体再氧合后给予等剂量照射。
  • 肿瘤与活检均在照射后24小时固定,并在氧合肿瘤区域评估γH2AX焦点。

主要发现

  • 线性回归分析显示,5种hHNSCC模型中4种的在体与离体队列残余γH2AX焦点剂量反应曲线斜率相近。
  • 离体活检与在体肿瘤的曲线斜率可按固有放射敏感性(TCD50)将相应肿瘤模型分类为敏感或抗拒。

临床怎么用

  • 离体γH2AX焦点检测有望作为反映肿瘤固有放射反应的诊断工具,但当前证据来自临床前异种移植模型。

局限性

  • 研究仅基于5种hHNSCC异种移植模型,5种中4种显示在体与离体曲线斜率相近。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: a) To investigate if an ex vivo cultured and irradiated tumor biopsy reflects and predicts the radiation response of the corresponding in vivo irradiated tumor measured with the DNA double strand break marker γH2AX foci. MATERIALS AND METHODS: Five human head and neck squamous cell carcinoma (hHNSCC) xenograft models were used. Fine needle biopsies were taken from anesthetized tumor-bearing NMRI nude mice prior to in vivo single dose irradiation (0, 2, 4, or 8 Gy) under ambient blood flow. Biopsies were ex vivo reoxygenated and irradiated with equivalent doses. Tumors and biopsies were fixed 24 h post irradiation, and γH2AX foci were assessed in oxygenated tumor regions. RESULTS: Linear regression analysis showed comparable slopes of the residual γH2AX foci dose-response curves in four out of five hHNSCC models when in vivo and ex vivo cohorts were compared. The slopes from ex vivo biopsies and in vivo tumors could classify the respective tumor model as sensitive or resistant according to the intrinsic radiation sensitivity (TCD50). CONCLUSION: The ability of ex vivo irradiated tumor biopsies to reflect and predict the intrinsic radiation response of in vivo tumors increases the translational potential of the ex vivo γH2AX foci assay as a diagnostic tool for clinical practice.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Rassamegevanon T, Löck S, Baumann M, et al. Comparable radiation response of ex vivo and in vivo irradiated tumor samples determined by residual γH2AX. Radiother Oncol. 2019. PMID: 31445839. doi:10.1016/j.radonc.2019.06.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。